Hepius Medical is developing smart cardiac catheter technology that enhances the precision of ablation therapy for patients with cardiac arrhythmia. This technology aims to improve patient safety and treatment efficacy by providing surgeons with real-time data during procedures.
Funding
$210K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Cardiac ablation, a common treatment for heart arrhythmias, relies on precise catheter placement to target problematic tissue. Inaccurate placement can lead to ineffective treatment or damage to surrounding healthy tissue, increasing the risk of complications. Current methods lack real-time feedback mechanisms to guide surgeons during the ablation procedure.
Solution
Hepius Medical is developing a smart cardiac catheter that provides surgeons with real-time data and enhanced precision during ablation therapy. This technology aims to improve patient safety and treatment efficacy by offering immediate feedback on catheter placement and tissue contact. The smart catheter integrates advanced sensors and signal processing to deliver actionable insights directly to the surgeon. By providing real-time data, Hepius Medical's technology enables more accurate and effective ablation procedures, potentially reducing the need for repeat procedures and minimizing complications.
Target Audience
The primary target audience includes electrophysiologists and cardiac surgeons performing ablation procedures for patients with heart arrhythmias.
Features
- Integrated sensors for real-time monitoring of catheter position and contact force
- Advanced signal processing algorithms to differentiate between healthy and targeted tissue
- Real-time feedback displayed on a surgical navigation system
- Enhanced precision in ablation delivery
- Compatibility with existing ablation generators